Prestige BioPharma Limited (950210.KS)

KRW 15050.0

(-4.57%)

Inventory Summary of Prestige BioPharma Limited

  • Prestige BioPharma Limited's latest annual inventory in 2023 was 18.1 Billion KRW , up 153.33% from previous year.
  • Prestige BioPharma Limited's latest quarterly inventory in 2023 Q3 was 7.8 Billion KRW , down -2.98% from previous quarter.
  • Prestige BioPharma Limited reported annual inventory of 7.14 Billion KRW in 2022, up 231.3% from previous year.
  • Prestige BioPharma Limited reported annual inventory of 2.15 Billion KRW in 2021, up 1483.73% from previous year.
  • Prestige BioPharma Limited reported quarterly inventory of 9.87 Billion KRW for 2023 Q1, up 38.17% from previous quarter.
  • Prestige BioPharma Limited reported quarterly inventory of 7.8 Billion KRW for 2023 Q3, down -2.98% from previous quarter.

Annual Inventory Chart of Prestige BioPharma Limited (2023 - 2017)

Historical Annual Inventory of Prestige BioPharma Limited (2023 - 2017)

Year Inventory Inventory Growth
2023 18.1 Billion KRW 153.33%
2022 7.14 Billion KRW 231.3%
2021 2.15 Billion KRW 1483.73%
2020 -155.87 Million KRW 93.58%
2019 -2.42 Billion KRW -242964735200.0%
2018 1.00 KRW 0.0%
2017 1.00 KRW 0.0%

Peer Inventory Comparison of Prestige BioPharma Limited

Name Inventory Inventory Difference
ORIENT BIO Inc. 3.65 Billion KRW -395.374%
Green Cross Holdings Corporation 579.72 Billion KRW 96.877%
Green Cross Holdings Corporation 516.24 Billion KRW 96.493%
Pharmicell Co., Ltd. 20.87 Billion KRW 13.268%
Green Cross Corporation 516.24 Billion KRW 96.493%
GeneOne Life Science, Inc. 14.89 Billion KRW -21.522%
Celltrion, Inc. 3041.45 Billion KRW 99.405%
Samsung Biologics Co.,Ltd. 2641.36 Billion KRW 99.315%
SK bioscience Co.,Ltd. 80.64 Billion KRW 77.553%
SK Biopharmaceuticals Co., Ltd. 102.52 Billion KRW 82.343%